The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC).
 
Lauren Christine Harshman
Consulting or Advisory Role - Dendreon; Genentech; KEW; Medivation/Astellas; NCCN; Pfizer; PlatformQ Health; Theragene
Research Funding - Bayer (Inst); Dendreon (Inst); Genentech/Roche (Inst); Medivation/Astellas (Inst); Sotio (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Maneka Puligandla
No Relationships to Disclose
 
Naomi B. Haas
No Relationships to Disclose
 
Mohamad Allaf
Research Funding - Progenics (Inst)
 
Charles G. Drake
Stock and Other Ownership Interests - Compugen; ImmunExcite; NexImmune; Potenza Therapeutics; Tizona Therapeutics, Inc.
Consulting or Advisory Role - Agenus; Astellas Medivation; AstraZeneca/MedImmune; Bristol-Myers Squibb (Inst); Compugen; Dendreon; ImmuneXcite; Janssen Oncology; Lilly; Merck; NexImmune; Pfizer; Pierre Fabre; Potenza Therapeutics; Roche/Genentech; Tizona Therapeutics, Inc.
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Compugen (Inst); Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patents licensed to BMS (Inst); Patents licensed to Potenza Therapeutics (Inst)
 
David F. McDermott
Consulting or Advisory Role - Alexion Pharmaceuticals; Array BioPharma; Bristol-Myers Squibb; Eisai; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)
 
Sabina Signoretti
Consulting or Advisory Role - AstraZeneca; Merck; Verastem
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - Biogenex
 
David Cella
Stock and Other Ownership Interests - FACIT.org
Consulting or Advisory Role - Abbvie; Bayer; GlaxoSmithKline; Pfizer
Research Funding - Bayer (Inst); Genentech (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; GlaxoSmithKline
 
Rajan T Gupta
No Relationships to Disclose
 
Rupal Satish Bhatt
No Relationships to Disclose
 
Eliezer Mendel Van Allen
Stock and Other Ownership Interests - Syapse
Consulting or Advisory Role - Genome Medical; Novartis; Roche; Syapse; Takeda; Third Rock Ventures
Research Funding - Bristol-Myers Squibb; Novartis
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - alligent; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Eisai; Exelixis; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Peloton Therapeutics; Pfizer; Prometheus; Roche/Genentech
Research Funding - Agensys (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - advisory boards/consultancy
 
Primo Lara
Honoraria - Pfizer
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Exelixis; Genentech/Roche; Halozyme; Janssen; Novartis; PER; Pfizer; Sanofi; Turnstone Bio
Research Funding - Aragon Pharmaceuticals (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Incyte (Inst); Janssen Biotech (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Polaris (Inst); TRACON Pharma (Inst)
 
Anil Kapoor
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst)
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
 
Brian M. Shuch
No Relationships to Disclose
 
Michael A.S. Jewett
Employment - Impact Genetics (I)
Leadership - Impact Genetics (I)
Stock and Other Ownership Interests - Impact Genetics (I)
Honoraria - Janssen Oncology; Myriad Genetics; Pfizer
Consulting or Advisory Role - Theralase
Research Funding - Olympus Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Patent application filed for a new RFA device
 
Daniel J. George
Honoraria - Bayer; Dendreon; Medivation; Novartis; Sanofi
Consulting or Advisory Role - Acceleron Pharma; Astellas Pharma; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Dendreon; Exelixis; Genentech; GlaxoSmithKline; Innocrin Pharma; Janssen; Medivation; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Dendreon; Novartis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Viamet Pharmaceuticals (Inst)
 
M Dror Michaelson
Employment - Jounce Therapeutics (I)
Consulting or Advisory Role - Exelixis; Medivation; Novartis; Pfizer
Research Funding - Argos Therapeutics (Inst); Eisai (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
 
Michael Anthony Carducci
Consulting or Advisory Role - Astellas Pharma; Churchill Pharmaceuticals; Medivation; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); pfizer (Inst)